Global Nanocapsules Market is segmented By Polymer Type (Natural Polymers, Synthetic Polymers), By Application (Pharmaceutical, Cosmeceuticals, Others), By Route of Administration (Parenteral Route, Oral Route), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Nanocapsules Market Overview
Global Nanocapsules market is expected to grow at a CAGR of 7.5% during the forecast period 2024- 2031.
Nanocapsules are a new branch of pharmacology that focuses on nanomedicine applications. Nanocapsules are drug delivery agents that range in size from 10nm to 1000nm and are typically made up of a capsule shell and a hollow space in which the desired substance or drug molecules are embedded. Nanocapsules can penetrate basal membranes due to their small size, making them appealing carriers for drug delivery. Because of their low aspect ratio, they can penetrate cells more easily than capsules with high aspect ratios, such as rods. Their surfaces can also be modified to recognize biomolecules and cell-surface receptors for targeted delivery. The types of polymers include synthetic and natural polymers.
Nanocapsules Market Scope
|
Metrics |
Details |
|
Market CAGR |
7.5% |
|
Segments Covered |
By Polymer Type, By Application, By Route of Administration, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
For more insights Request Free Sample
Nanocapsules Market Dynamics
The rising prevalence of chronic diseases worldwide has created a demand for innovative and efficient drug delivery systems that can deliver the required quantity of medications at the site of action at a specified time. The rising adoption of nanocapsules in the food and pharmaceutical industries is expected to drive the market in the forecast period.
The rising adoption of nanocapsules in oncology is expected to drive market growth.
The use of nanotechnology in medicine has the potential to be very beneficial, particularly in oncology, which has given rise to the new discipline of nanooncology. A wide range of chemotherapeutic or diagnostic chemicals can be included in nanoparticles through engineering. A nanocapsule is a vesicular device with a core-shell structure that confines active molecules to a reservoir or cavity encased in a polymer membrane or coating. Delivery methods based on nanocapsules are often delivered to a specific tumor site, where they release their contents in response to environmental changes. Many cancer treatments struggle to effectively distribute the therapeutic drug to the tumor site and the malignant cells that have already infiltrated the tissue. Therefore, nanoencapsulated systems provide the necessary physicochemical properties and alter the biodistribution of the medicinal substances they contain. Higher payloads, protection against degradation of the active molecules, extended drug circulation times, and delayed drug release are all possible with nanocapsules. They can also increase medication targeting and solubility, promote cellular uptake, and offer controlled release.
Furthermore, the self-degrading nanocapsule approach could be useful in protein drugs or vaccines, and it could be extended to applications in which external proteases cause the nanocapsules to disassemble. For diagnostic and therapeutic purposes, encapsulated radioactive components can allow imaging of the distribution of the targeted NCs. Antibodies can be attached to the nanocapsule surface, and antibody-functionalized nanocapsules can bind to cancer cells expressing the complementary antigen. Thus, from the above factors, the market is expected to drive in the forecast period.
The disadvantages of nanocapsules are expected to hamper the market growth.
Productivity is more difficult due to the high cost of the formulation and its low yield. As an industrial application, technology transfer to commercial production is extremely difficult. The reduced ability to adjust the dose, Advanced technology and manufacturing require certain skills. Because of its nano size, dosage form stability is a major issue, and recycling is very expensive. Thus, from the above factors, the market is expected to hamper in the forecast period.
COVID-19 Impact on Nanocapsules Market
The COVID-19 pandemic has increased demand for various therapeutic drugs, and developing new drugs is expected to boost the market for nanocapsules. The market is expected to grow rapidly in the post-pandemic period due to increased investment in targeted drug delivery systems. In targeted drug delivery and vaccination, surface modification and functionalization of quantum and nanomaterials are critical in terminating the life cycle of the viral infection. As a drug carrier, nanocarriers such as micelles, liposomes, dendrimers, and nanocapsules can stop virus replication by entrapping, encapsulating, dissolving, absorbing, or chemically bonding to the virus and causing it to malfunction. Organic nanocarriers such as liposomes, niosomes, polymeric nanoparticles, nanocapsules, micelles, and dendrimers are used in drug delivery. Hence, the above factors positively impact the market in the forecast period.
Nanocapsules Market Segmentation Analysis
Synthetic Polymers segment is expected to hold the largest market share in nanocapsules
The synthetic polymers segment accounted for the largest market share in 2021. Synthetic materials can be produced with consistent quality and purity and have benefits over natural ones. Additionally, depending on the many pharmaceutical uses, they can be customized with various chemical, ionic, mechanical, solubility, and degradability properties. Moreover, due to their biocompatibility and biodegradability, aliphatic polyesters and related copolymers, widespread synthetic polymers, have been extensively researched and developed as drug delivery systems. The three most popular types of polyester are poly (lactic acid), poly (lactic-co-glycolic acid), and poly (-caprolactone) (PCL). PCLs can offer a significantly longer degradation period than PLA and PLGA copolymers. As a result, PCLs are better suited for medicinal or long-term drug delivery systems. According to some research, it is also advantageous that PCLs are less expensive than PLAs and PLGAs.
Furthermore, Eudragit polymers are a class of synthetic polymers with varying acrylate and methacrylate content that are used as coating materials for various dosage forms in pharmaceutical applications due to their biocompatibility, biodegradability, and flexible ionic properties. Eudragit polymers were considered for the formulation of the shell of nanocapsules. For example, Eudragit RS100 has created a polymeric shell to deliver dihydromyricentin. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.
Nanocapsules Market Geographical Share
North America region holds the largest market share in the global nanocapsules market
North America region accounted for the largest market share in 2021. The increasing prevalence of chronic disease, the rising number of cancer cases, the rise in the demand for nanocapsules, increasing investments in nanocapsules for new drug development in cancer and collaborations by the key market players are the factors to drive the market in the forecast period. For instance, in 2021, Delta 9 signed a licensing agreement with Nanosphere Health Sciences. This collaboration will significantly impact the recreational market and the medicinal use of cannabis in Canada and around the world. Because Nanosphere is a nano-biotechnology organization focused on delivering dietary elements and medicines in the coming decade. The company's proprietary NanoSphere Delivery System platform technology addresses the problems of poor bioactivity and disproportionate dose levels of a wide range of bioactive components, particularly cannabinoids. This system is the main functional component of this agreement. Thus, from the above factors, the North American region accounted for the largest market share in the forecast period.
Nanocapsules Market Companies
Major key players in the nanocapsules market are BioDelivery Sciences, Camurus, Capsulation, Carlina Technologies, Cerulean Pharma Inc., Encap, Indian Instruments Manufacturing Company, L’Oreal, NanoNutra, NanoSphere Health Science, NoCamels, PlasmaChem GmbH, Sanzyme Ltd. and Sintef.
L'Oréal:
Overview:
L'Oréal Company was founded by Eugène Schueller in 1909 and is headquartered in Clichy, France. The company manufactures and sells beauty and hair care products. Professional Products, Consumer Products, L'Oréal Luxe, and Active Cosmetics are its business segments. The Professional Products segment creates and sells products used and sold in hair salons. The Consumer Products segment sells beauty and personal care products to men and women through mass-market retail channels. L'Oréal Luxe sells high-end skincare and beauty products in select retail locations such as department stores, perfumeries, and travel retail. The Active Cosmetics segment sells dermo-cosmetic skincare products in pharmacies and drugstore specialty sections.
Product Portfolio:
Primordiale Intense: L'Oréal marketed Primordiale Intense uses nanocapsules to encapsulate various active ingredients. Primordiale Intense works deep within the skin's surface using pure vitamin E with sunflower seed extract to help repair the sign of past damage and protect from future harm. Primordiale Intense fades away fine lines while improving skin texture.
The global nanocapsules market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
